Clinical Trial Phases
Lotus Lab exhibits leadership and a proven track record in the effective conduct of Clinical trial phases.The effective management of Clinical trial phases, specifically the Phase II-IV trials is reflected in the fact that we have strategic relationships with reputed hospitals and have worked with more than 600 clinical sites. This ensures that we always have access to a large database spanning diverse therapeutic areas to effectively conduct Clinical trial phases that would eventually further the prospects of path breaking proprietary diagnostics and therapies.
 
Capabilities 
 
At Lotus Labs, our research programs employ the latest study designs in clinical pharmacology, bio-analytical method development and Pharmacokinetic analysis, conducted by a team of experienced and well-trained clinical coordinators and research associates.
Our 360o approach to Clinical trial phases ensures that sponsors benefit from the entire gamut of services:
  • Feasibility Studies
  • Volunteer Recruitment & Planning
  • Clinical Trial Supplies & Management
  • Project Management, Clinical Monitoring
  • Bio Statistics
  • Pharmacy Services – ensuring strict adherence to GCP and other international regulatory requirements. 

Lotus has rich experience in conducting multi-centric, multi-national clinical trial phases with patient groups ranging from 15 to 1500 for USFDA and other regulated markets. We offer clinical sites spread across Europe in partnership with reputed channel partners.  

We have worked with over 200 clinical sites in India and Bangladesh, where we have recruited over 3,000 patients for various clinical trials.